• 25 July 2018

    Breast cancer device from Endomag receives FDA approval

    Surgical guidance firm Endomag has announced that the US Food and Drug Administration (FDA) has granted premarket approval for the company’s breast cancer device Magtrace, the first non-radioactive dual-tracer for...

  • 3 July 2018

    Low-cost prosthetic foot facilitates natural walking

    MIT engineers have developed a simple, low-cost, prosthetic foot that can be tailored for individual patients. By using a patient’s body weight and size, the researchers can tune the shape...

Go Top